Longitudinal Adherence to Antiretroviral Drugs for Preventing Mother-To-Child Transmission of HIV in Zambia

Adherence to antiretroviral (ARV) drugs is essential for eliminating new pediatric infections of human immunodeficiency virus (HIV). Since the Zambian government revised the national guidelines based on option A (i.e., maternal zidovudine and infant ARV prophylaxis) of the World Health Organization’s 2010 guidelines, no studies have assessed adherence to ARVs during pregnancy up to the postpartum period. This study aimed to examine adherence to ARVs and identify the associated risk factors.

A prospective cohort study was conducted in the Chongwe district from June 2011 to January 2014. Self-reported adherence to ARVs was examined during pregnancy and at one week, six weeks, and 24 weeks postpartum among 321 HIV-positive women. The probability of remaining adherent to ARVs was estimated using the Kaplan-Meier method, and the risk factors for non-adherence were identified using the Cox proportional hazard regressions—treating loss to follow-up as non-adherence. The statuses of HIV in HIV-exposed infants were assessed in January 2014.

During the study period, 326 infants were born to HIV-positive women, 262 (80.4 %) underwent HIV testing, and 11 (3.4 %) had their HIV infection detected at the time that they had the latest HIV testing as of January 2014. The ARV adherence rate was 82.5 % during pregnancy, 84.2 % at one week postpartum, 81.5 % at six weeks postpartum, and 70.5 % at 24 weeks postpartum. The probability of remaining adherent to ARVs was 0.61 at day 50, 0.35 at day 100, 0.18 at day 200, and 0.06 at day 300. Attending a referral health center (HC) was a risk factor for non-adherence compared with attending rural HCs that provided HIV care/treatment (adjusted hazard ratio [aHR] 0.71, 95 % confidence interval [CI] 0.57–0.88) and those that did not provide HIV care/treatment (aHR 0.58, 95 % CI 0.46–0.74). A new diagnosis of HIV infection compared to a known HIV-positive status before pregnancy was another risk factor for non-adherence (aHR 1.24, 95 % CI 1.03–1.50).

Maintaining adherence to ARVs through pregnancy to the postpartum period remains a crucial challenge in Zambia. To maximize the treatment benefits, adherence to ARVs and retention in care should be improved at all health facilities.

Below:  Probability of remaining adherent to ARVs. Definition of non-adherence to ARVs (secondary definition) includes: missed doses; not following prescribed schedule; missed visiting for scheduled interview; loss to follow up; and infant deaths

Full article at: http://goo.gl/rnNt5G

By: Sumiyo Okawa¹, Mable Chirwa²³, Naoko Ishikawa^4*, Henry Kapyata²³, Charles Yekha Msiska²³, Gardner Syakantu⁵, Shinsuke Miyano⁴, Kenichi Komada³⁴, Masamine Jimba¹and Junko Yasuoka¹

¹Department of Community and Global Health, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

²Chongwe District Community Health Office, Chongwe, Zambia

³Ministry of Health Zambia-Japan International Cooperation Agency SHIMA project, Lusaka, Zambia

⁴National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku-ku 162-8655, Tokyo, Japan

⁵Ministry of Health, Lusaka, Zambia

  

More at:  https://twitter.com/hiv_insight